FoundationOne® CDx - P170019/S017 | FDA
https://www.fda.gov/medical-devices/recently-approved-devices/foundationoner-cdx-p170019s017
What Is It?How Does It Work?When Is It used?What Will It Accomplish?Additional Information (Including Warnings, Precautions, and Adverse Events) FoundationOne CDx (F1CDx) is a laboratory test designed to detect genetic variations in 324 genes. F1CDx is a companion diagnostic that has been approved for the detection of genetic mutations in patients who may benefit from one of twenty-three FDA-approved therapies for non-small cell lung cancer, melanoma, breast cancer, colorectal cancer, ovari...
FoundationOne CDx (F1CDx) is a laboratory test designed to detect genetic variations in 324 genes. F1CDx is a companion diagnostic that has been approved for the detection of genetic mutations in patients who may benefit from one of twenty-three FDA-approved therapies for non-small cell lung cancer, melanoma, breast cancer, colorectal cancer, ovari...
DA: 36 PA: 20 MOZ Rank: 61
